首页|期刊导航|传统医学研究（英文版）|Simiao Wan alleviates obesity-associated insulin resistance via PKCε/IRS-1/PI3K/Akt signaling pathway based on network pharmacology analysis and experimental validation

Simiao Wan alleviates obesity-associated insulin resistance via PKCε/IRS-1/PI3K/Akt signaling pathway based on network pharmacology analysis and experimental validation

Jing Jin Yin-Yue Xu Wen-Ping Liu Ke-Hua Hu Ning Xue Zu-Guo Zheng

传统医学研究（英文版）2023，Vol.8Issue(10)：56-68,13.

传统医学研究（英文版）2023，Vol.8Issue(10)：56-68,13.DOI:10.53388/TMR20230512002

Simiao Wan alleviates obesity-associated insulin resistance via PKCε/IRS-1/PI3K/Akt signaling pathway based on network pharmacology analysis and experimental validation

Jing Jin ¹Yin-Yue Xu ¹Wen-Ping Liu ¹Ke-Hua Hu ¹Ning Xue ²Zu-Guo Zheng¹

作者信息

1. State Key Laboratory of Natural Medicines,China Pharmaceutical University,Nanjing 210009,China
2. Department of Acupuncture,Jurong Hospital Affiliated to Jiangsu University,Zhenjiang 212499,China
折叠

摘要

关键词

Simiao Wan/insulin resistance/PKCε/IRS-1/PI3K/Akt signaling pathway/network pharmacology/DAG

Key words

Simiao Wan/insulin resistance/PKCε/IRS-1/PI3K/Akt signaling pathway/network pharmacology/DAG

引用本文复制引用

Jing Jin,Yin-Yue Xu,Wen-Ping Liu,Ke-Hua Hu,Ning Xue,Zu-Guo Zheng..Simiao Wan alleviates obesity-associated insulin resistance via PKCε/IRS-1/PI3K/Akt signaling pathway based on network pharmacology analysis and experimental validation[J].传统医学研究（英文版）,2023,8(10):56-68,13.

基金项目

This work was supported by the National Natural Science Foundation of China(81903871),Natural Science Foundation of Jiangsu Province(BK20190565),Fundamental Research Funds for the Central Universities(2632021ZD16),and Zhenjiang City 2022 Science and Technology Innovation Fund(SH2022084). （81903871）

传统医学研究（英文版）

ISSN：2413-3973

访问量3

下载量0

段落导航